Vaccines
19 February 2020
Sanofi joins forces with U.S. Department of Health and Human Services to advance a novel coronavirus vaccine17 February 2020
Zydus Cadila launches a fast tracked programme to develop vaccine for the novel coronavirus, 2019-nCoV (COVID-19)16 February 2020
Vaxil Announces the Identification of a Potential Corona Virus Vaccine and Provides an Update in the Previously Announced Debt Financing10 February 2020
Inovio receives authorization from U.S. FDA to begin Phase 1/2 trial for INO-3107 to treat RRP10 February 2020
Clover Successfully Produced 2019-nCoV Subunit Vaccine Candidate and Detected Cross-Reacting Antibodies from Sera of Multiple Infected Patients3 February 2020
Seqirus Announces U.S. FDA Approval of Its First-Ever Adjuvanted, Cell-Based Pandemic Influenza A (H5N1) Vaccine3 February 2020
CEPI and GSK announce collaboration to strengthen the global effort to develop a vaccine for the 2019-nCoV virus2 February 2020
Johnson & Johnson Launches Multi-Pronged Response to Coronavirus Global Public Health Threat2 February 2020
CureVac and CEPI extend their Cooperation to Develop a Vaccine against Coronavirus nCoV-20192 February 2020
Vaxart Announces Initiation of Coronavirus Vaccine Program2 February 2020
Emergent BioSolutions Receives Positive CHMP Opinion for Vaxchora; Anticipates Near-Term Approval by European Medicines Agency30 January 2020
Inovio collaborating with Beijing Advaccine to advance INO-4800 vaccine against new coronavirus in ChinaNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports